Show simple item record

dc.contributor.authorLaque, A.
dc.contributor.authorKoya, E.
dc.contributor.authorHope, B.T.
dc.contributor.authorElmer, G.I.
dc.date.accessioned2019-09-14T14:28:32Z
dc.date.available2019-09-14T14:28:32Z
dc.date.issued2019
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85071751551&doi=10.1038%2fs41467-019-11799-1&partnerID=40&md5=9541d76276dc32549a7221c807f007cb
dc.identifier.urihttp://hdl.handle.net/10713/10825
dc.description.abstractDrug addiction is a chronic relapsing disorder of compulsive drug use. Studies of the neurobehavioral factors that promote drug relapse have yet to produce an effective treatment. Here we take a different approach and examine the factors that suppress—rather than promote—relapse. Adapting Pavlovian procedures to suppress operant drug response, we determined the anti-relapse action of environmental cues that signal drug omission (unavailability) in rats. Under laboratory conditions linked to compulsive drug use and heightened relapse risk, drug omission cues suppressed three major modes of relapse-promotion (drug-predictive cues, stress, and drug exposure) for cocaine and alcohol. This relapse-suppression is, in part, driven by omission cue-reactive neurons, which constitute small subsets of glutamatergic and GABAergic cells, in the infralimbic cortex. Future studies of such neural activity-based cellular units (neuronal ensembles/memory engram cells) for relapse-suppression can be used to identify alternate targets for addiction medicine through functional characterization of anti-relapse mechanisms. Copyright 2019, The Author(s).en_US
dc.description.sponsorshipThis work was supported by the Extramural and Intramural funding from National Institute on Drug Abuse as well as National Institute of Alcohol Abuse and Alcoholism, National Institute of Health, USA: R21DA033533 (N.S.), R01DA037294 (N.S.), R01AA023183 (N.S.), R01AA021549 (F.W.), ZIADA000467 (B.T.H.), N01DA59909 (G.I. E.). A.L. and H.N. were supported by Ruth L. Kirschstein Institutional National Research Service Award from National Institute of Alcohol Abuse and Alcoholism, National Institute of Health, USA: T32AA007456 (PIs, Drs. Loren “Larry” Parsons and Michael Taffe).en_US
dc.description.urihttps://doi.org/10.1038/s41467-019-11799-1en_US
dc.language.isoen-USen_US
dc.publisherNature Publishing Groupen_US
dc.relation.ispartofNature Communications
dc.subjectrelapse suppressionen_US
dc.subject.meshSubstance-Related Disordersen_US
dc.titleAnti-relapse neurons in the infralimbic cortex of rats drive relapse-suppression by drug omission cuesen_US
dc.typeArticleen_US
dc.identifier.doi10.1038/s41467-019-11799-1
dc.identifier.pmid31477694


This item appears in the following Collection(s)

Show simple item record